Annual SG&A:
$0.00-$37.02M(-100.00%)Summary
- As of today, VKTX annual SG&A is $0.00, with the most recent change of -$37.02 million (-100.00%) on December 31, 2024.
- During the last 3 years, VKTX annual SG&A has fallen by -$10.70 million (-100.00%).
- VKTX annual SG&A is now -100.00% below its all-time high of $37.02 million, reached on December 31, 2023.
Performance
VKTX SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$0.00-$14.42M(-100.00%)Summary
- As of today, VKTX quarterly SG&A is $0.00, with the most recent change of -$14.42 million (-100.00%) on September 30, 2025.
- Over the past year, VKTX quarterly SG&A has dropped by -$13.77 million (-100.00%).
- VKTX quarterly SG&A is now -100.00% below its all-time high of $15.25 million, reached on December 31, 2024.
Performance
VKTX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$2.31B-$237.39M(-11.45%)Summary
- As of today, VKTX TTM SG&A is -$2.31 billion, with the most recent change of -$237.39 million (-11.45%) on September 30, 2025.
- Over the past year, VKTX TTM SG&A has dropped by -$2.35 billion (-5497.05%).
- VKTX TTM SG&A is now -566180.39% below its all-time high of -$408.00 thousand.
Performance
VKTX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
VKTX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -100.0% | -100.0% | -5497.1% |
| 3Y3 Years | -100.0% | -100.0% | -10000.0% |
| 5Y5 Years | -100.0% | -100.0% | -10000.0% |
VKTX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -100.0% | at low | -100.0% | at low | -133.0% | at low |
| 5Y | 5-Year | -100.0% | at low | -100.0% | at low | -303.7% | at low |
| All-Time | All-Time | -100.0% | at low | -100.0% | at low | >-9999.0% | at low |
VKTX Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $0.00(-100.0%) | $43.75M(-23.9%) |
| Jun 2025 | - | $14.42M(+2.4%) | $57.52M(+7.7%) |
| Mar 2025 | - | $14.08M(-7.7%) | $53.38M(+8.3%) |
| Dec 2024 | $0.00(-100.0%) | $15.25M(+10.7%) | $49.28M(+15.1%) |
| Sep 2024 | - | $13.77M(+33.9%) | $42.81M(+12.9%) |
| Jun 2024 | - | $10.29M(+3.2%) | $37.92M(+1.2%) |
| Mar 2024 | - | $9.97M(+13.5%) | $37.46M(+1.2%) |
| Dec 2023 | $37.02M(+129.6%) | $8.78M(-1.2%) | $37.02M(+14.5%) |
| Sep 2023 | - | $8.89M(-9.5%) | $32.34M(+16.8%) |
| Jun 2023 | - | $9.82M(+3.1%) | $27.69M(+26.1%) |
| Mar 2023 | - | $9.53M(+132.1%) | $21.96M(+36.2%) |
| Dec 2022 | $16.12M(+50.6%) | $4.11M(-3.1%) | $16.12M(+9.8%) |
| Sep 2022 | - | $4.24M(+3.6%) | $14.68M(+12.5%) |
| Jun 2022 | - | $4.09M(+10.8%) | $13.05M(+11.6%) |
| Mar 2022 | - | $3.69M(+38.6%) | $11.70M(+9.3%) |
| Dec 2021 | $10.70M(-0.3%) | $2.66M(+2.1%) | $10.70M(+4.3%) |
| Sep 2021 | - | $2.61M(-4.7%) | $10.26M(-1.1%) |
| Jun 2021 | - | $2.74M(+1.6%) | $10.37M(-0.9%) |
| Mar 2021 | - | $2.69M(+21.5%) | $10.46M(-2.5%) |
| Dec 2020 | $10.73M(+17.6%) | $2.22M(-18.7%) | $10.73M(-1.9%) |
| Sep 2020 | - | $2.73M(-3.5%) | $10.94M(+5.5%) |
| Jun 2020 | - | $2.83M(-4.6%) | $10.37M(+6.0%) |
| Mar 2020 | - | $2.96M(+22.3%) | $9.78M(+7.1%) |
| Dec 2019 | $9.13M | $2.42M(+12.1%) | $9.13M(+5.5%) |
| Sep 2019 | - | $2.16M(-3.4%) | $8.65M(+5.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | $2.24M(-3.2%) | $8.20M(+6.9%) |
| Mar 2019 | - | $2.31M(+18.6%) | $7.67M(+7.7%) |
| Dec 2018 | $7.12M(+33.6%) | $1.95M(+14.1%) | $7.12M(+8.4%) |
| Sep 2018 | - | $1.71M(+0.2%) | $6.57M(+7.9%) |
| Jun 2018 | - | $1.70M(-3.3%) | $6.09M(+7.7%) |
| Mar 2018 | - | $1.76M(+26.4%) | $5.65M(+6.0%) |
| Dec 2017 | $5.33M(+9.9%) | $1.39M(+13.6%) | $5.33M(+6.1%) |
| Sep 2017 | - | $1.23M(-3.2%) | $5.02M(+1.4%) |
| Jun 2017 | - | $1.27M(-12.0%) | $4.96M(+1.2%) |
| Mar 2017 | - | $1.44M(+32.1%) | $4.90M(+1.0%) |
| Dec 2016 | $4.85M(-3.6%) | $1.09M(-6.0%) | $4.85M(-6.0%) |
| Sep 2016 | - | $1.16M(-3.9%) | $5.16M(-10.7%) |
| Jun 2016 | - | $1.21M(-13.2%) | $5.78M(-5.2%) |
| Mar 2016 | - | $1.39M(-0.8%) | $6.10M(+21.2%) |
| Dec 2015 | $5.03M(+304.0%) | $1.40M(-21.3%) | $5.03M(+38.6%) |
| Sep 2015 | - | $1.78M(+16.7%) | $3.63M(+96.4%) |
| Jun 2015 | - | $1.53M(+373.8%) | $1.85M(+121.0%) |
| Mar 2015 | - | $322.10K(-37.3%) | $836.10K(+40.4%) |
| Dec 2014 | $1.24M(+1290.9%) | - | - |
| Jun 2014 | - | $514.00K(+530.7%) | $595.50K(+526.2%) |
| Mar 2014 | - | $81.50K(+499.3%) | $95.10K(+66.8%) |
| Dec 2013 | $89.50K(+119.4%) | - | - |
| Jun 2013 | - | $13.60K(+423.1%) | $57.00K(+31.3%) |
| Mar 2013 | - | $2600.00(-93.6%) | $43.40K(+6.4%) |
| Dec 2012 | $40.80K | $40.80K | $40.80K |
FAQ
- What is Viking Therapeutics, Inc. annual SG&A?
- What is the all-time high annual SG&A for Viking Therapeutics, Inc.?
- What is Viking Therapeutics, Inc. annual SG&A year-on-year change?
- What is Viking Therapeutics, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for Viking Therapeutics, Inc.?
- What is Viking Therapeutics, Inc. quarterly SG&A year-on-year change?
- What is Viking Therapeutics, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for Viking Therapeutics, Inc.?
- What is Viking Therapeutics, Inc. TTM SG&A year-on-year change?
What is Viking Therapeutics, Inc. annual SG&A?
The current annual SG&A of VKTX is $0.00
What is the all-time high annual SG&A for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high annual SG&A is $37.02M
What is Viking Therapeutics, Inc. annual SG&A year-on-year change?
Over the past year, VKTX annual SG&A has changed by -$37.02M (-100.00%)
What is Viking Therapeutics, Inc. quarterly SG&A?
The current quarterly SG&A of VKTX is $0.00
What is the all-time high quarterly SG&A for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high quarterly SG&A is $15.25M
What is Viking Therapeutics, Inc. quarterly SG&A year-on-year change?
Over the past year, VKTX quarterly SG&A has changed by -$13.77M (-100.00%)
What is Viking Therapeutics, Inc. TTM SG&A?
The current TTM SG&A of VKTX is -$2.31B
What is the all-time high TTM SG&A for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high TTM SG&A is -$408.00K
What is Viking Therapeutics, Inc. TTM SG&A year-on-year change?
Over the past year, VKTX TTM SG&A has changed by -$2.35B (-5497.05%)